Commodore Capital LP Acquires 9.9% Passive Stake in Editas Medicine, Inc.

On June 2, 2026, Commodore Capital LP and its affiliates filed a Schedule 13G disclosing a new significant stake in Editas Medicine, Inc. (EDIT). As of the event date on May 26, 2026, the filers reported beneficial ownership of 16,045,802 shares of Common Stock, representing 9.9% of the company. This position consists of 8,889,000 shares of Common Stock and 7,156,802 shares underlying Common Warrants. The filing notes that the total ownership is limited by a 9.99% beneficial ownership blocker, which currently excludes an additional 1,732,198 shares underlying the warrants. The reporting group includes Commodore Capital LP, Commodore Capital Master LP, and managing partners Robert Egen Atkinson and Michael Kramarz, who exercise shared voting and dispositive power over the securities. This investment is categorized as passive, as the filers certified that the shares were not acquired for the purpose of influencing or changing the control of the issuer.